Towseef Amin Rafeeqi

Towseef Amin Rafeeqi

Auto-generated profile, based on publicly available information

Towseef Amin Rafeeqi

Research officer, Biochemistry, Regional Research Institute of Unani Medicine, Srinagar, J&K, India

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2022 in European Journal of Integrative Medicine
Verified
Journal Article
Closed access
TRTariq Rahi
Tariq Rahi
NINaqueeb Ul Islam
Naqueeb Ul Islam
RPRiyaz Ahmed Pandith
Riyaz Ahmed Pandith
SASeema Akbar
Seema Akbar
TRTowseef Amin Rafeeqi
Towseef Amin Rafeeqi

15 March 2024 in Journal of Drug Delivery and Therapeutics
Verified
Journal Article
Open access
PDF file
JAJosee Amin
Josee Amin
NINaquibul Islam
Naquibul Islam
TRTowseef Amin Rafeeqi
Towseef Amin Rafeeqi
Objectives: The objectives of this study were to observe the Efficacy of unani pharmacopoeial formulation Boozidan (Pyrethrum indicum) for the management of Niqris Muzmin (Chronic gout) and to observe any concomitant and adverse effects of formulation. Methods: This single blind, randomized and standard control clinical study was conducted between April 2021 to October 2021 for a period of 28 days. 60 patients diagnosed with chronic gout were divided into two groups, 30 Test group and 30 Control group. The test group was administered with 5g boozidaan in powder form once daily with water and the patients of control group were given tablet febuxostat 80mg once daily. Patients were followed up and improvements in subjective parameters were assessed weekly at 7th, 14th, 21st, and 29th day. Objective parameters were assessed at the baseline and at 29th day. The data obtained was subjected to statistical analysis. Results: Both the test and control drug were effective in reducing Serum uric acid level, ESR and CRP levels. A significant improvement in subjective and objective parameters was observed in both test and control groups and no adverse effects were observed during and after the study. However, the test drug had superior efficacy in reducing the objective parameters and it was statistically significant (p-value<0.0001). Conclusion: Both Boozidaan and Febuxostat were safe and significantly effective in resolving the symptoms and signs of gouty arthritis and both have significant effect on reducing serum uric acid level. Keywords: Boozidaan, Chronic gout, Niqris, Febuxostat, serum uric acid, unani medicine

7 February 2025 in Journal of Herbal Medicine
Verified
Journal Article
Closed access
TRTowseef Amin Rafeeqi
Towseef Amin Rafeeqi
RPRiyaz Ahmed Pandith
Riyaz Ahmed Pandith
HUHumma
Humma
ASArjumand Shah
Arjumand Shah
MZMohammad Zakir
Mohammad Zakir
NAN. Zaheer Ahmed
N. Zaheer Ahmed

17 March 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
URUzma Rehman
Uzma Rehman
ZHZaffar Hussain
Zaffar Hussain
TRTowseef Amin Rafeeqi
Towseef Amin Rafeeqi
Background: Unani System of medicine provides an alternative source to relieve the symptoms of Rheumatoid Arthritis, to slow the progression of disease, and to tackle the disadvantages associated with conventional drugs. Habb-e-Asgand is an important Unani pharmacopeial formulation which is commonly prescribed for Rheumatoid Arthritis. Hence, current study is designed to investigate its efficacy and safety in the management of Waja‘ al-Mafāṣil (Rheumatoid Arthritis).Methods: This parallel group, randomized, single blind clinical trial compared unani formulation Habb-e-Asgand 2pills (each of 650mg) at bed time orally, with Sulfasalazine 500 mg tablets twice a day orally as control. The total number of patients completing the trial was 20 in each group and treatment was given for 45 days. For evaluating subjective parameters, patients were asked to follow up every 15 days during the trial and objective parameters were assessed on the 0th and 46th days of the trial.Results: There was statistically significant difference between Test and Control treatment with respect to subjective parameters, joint pain (p-value˂0.0001*), morning stiffness (pvalue˂0.0001*), joints swelling (p-value˂0.0001*), joints tenderness (p-value˂0.0001*), restricted movement of the joints (p-value˂0.002*) which means that the treatments in the test group were more effective in resolving them. The objective parameter such as HAQ-DI, DAS-28, RA factor and soft tissue swelling on x-ray show statistically significant reduction in test group in comparison to the control group with p-value.Conclusion: These finding suggested that Habb-e-Asgand is safely and effectively used in the management of Waja‘ al-Mafāṣil (Rheumatoid Arthritis).Trial registration: CTRI no.- CTRI/2022/01/039602.

21 December 2019 in Journal of Complementary and Integrative Medicine
Verified
Journal Article
Closed access
PDF file
TRTowseef Amin Rafeeqi
Towseef Amin Rafeeqi
FJFarhat Jabeen
Farhat Jabeen
MWM A Waheed
M A Waheed
GHGulam Mohammed Husain
Gulam Mohammed Husain
ACAlokananda Chakraborthy
Alokananda Chakraborthy
Background: Vitiligo, a skin disorder is viewed as a multifactorial process with major role of reactive oxygen species in concert to destroy or incapacitate melanocytes. In Unani system of medicine the treatment of Bars (Vitiligo) starts with removal of harmful materials from the body with Munzij and Mushil (MM), a poly herbal Unani formulation. Methods: Herein, oxidative stress related parameters as MDA, SOD, GPx and CAT have been estimated in the 21 clinically diagnosed Vitiligo in-patients and subsequently these parameters were evaluated during and after administration of MM therapy and compared with 21 healthy subjects. Results: There was significant difference in the parameters viz., SOD (p<0.001) and CAT (p<0.005) activity at the baseline with no statistical significant difference in MDA and GPx activity among Vitiligo subjects and controls. After MM therapy there was no statistical significant difference among the values of these parameters in Vitiligo subjects. Conclusions: The results suggest that there is imbalance in the oxidant-antioxidant status of Vitiligo subjects and the MM therapy is not found to significantly change the levels of oxidative stress related parameters.

30 December 2021 in Journal of Ayurvedic and Herbal Medicine
Verified
Journal Article
Open access
TRTariq Rahi
Tariq Rahi
NINaquibul Islam
Naquibul Islam
TRTowseef Amin Rafeeqi
Towseef Amin Rafeeqi